doi: 10.3390/biom5020545 Lenton, K., San, A., Therriault, H., Cantin, A., Payette, H., & Wagner, J
When caloric intake decreases substantiallyas commonly occurs with GLP-1 therapy due to appetite suppression and early satietythe body mobilizes both fat and muscle tissue for energy
GLP-1 medications have gained attention for their role in managing type 2 diabetes and supporting weight loss when prescribed by a healthcare professional
Prior to metabolism in the mitochondria, the acetyl group is transferred to coenzyme A (CoA) to form acetyl-CoA, which enters the TCA cycle to generate ATP through oxidative phosphorylation
Acetylcarnitine also enhances mitochondrial energy production in neurons, which are highly energy-dependent cells
Diabetes Care 40 , 6976 (2017)